Tosedostat

Tosedostat
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2008-12-10 00:00:00
Sponsor CTI BioPharma Corporation;3101 Western Avenue, Suite 600;Seattle, Washington, 98121
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia